ELEVATED PLASMA HYALURONAN LEVELS IS A RISK FACTOR FOR MAJOR ADVERSE CARDIOVASCULAR EVENTS IN UROLOGICAL SEPSIS

被引：0
|
作者：
Momota, Masaki
Fujita, Naoki
Tobisawa, Yuki
Yoneyama, Tohru
Soma, Osamu
Noro, Daisuke
Ito, Hiroyuki
Yoshikawa, Ka
Ohyama, Chikara
Hatakeyama, Shingo
机构：
来源：
JOURNAL OF UROLOGY | 2024年 / 211卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
MP69-10
引用
收藏
页码：E1122 / E1122
页数：1
相关论文
共 50 条
  • [41] STROKE IS AN IMPORTANT PERIOPERATIVE RISK FACTOR AND PREDICTS MAJOR ADVERSE CARDIOVASCULAR EVENTS AFTER ELECTIVE SURGERY
    Joergensen, Mads E.
    Torp-Pedersen, Christian
    Gislason, Gunnar H.
    Andersson, Charlotte
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 61 (10) : E1363 - E1363
  • [42] Major Adverse Kidney Events in Pediatric Sepsis
    Weiss, Scott L.
    Balamuth, Fran
    Thurm, Cary W.
    Downes, Kevin J.
    Fitzgerald, Julie C.
    Laskin, Benjamin L.
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2019, 14 (05): : 664 - 672
  • [43] MAJOR ADVERSE CARDIOVASCULAR EVENTS AND GASTROINTESTINAL BLEEDING DURING SEPSIS AND THEIR IMPACTS ON HOSPITALIZATION OUTCOMES
    Hsieh, Ming-Shun
    Hsieh, Vivian Chia-Rong
    How, Chorng-Kuang
    Hu, Sung-Yuan
    Seak, Chen-June
    Chen, Pau-Chung
    Liao, Shu-Hui
    RESPIROLOGY, 2018, 23 : 255 - 256
  • [44] Elevated blood acetoacetate levels reduce major adverse cardiac and cerebrovascular events risk in acute myocardial infarction
    Sato, Jun
    Kinoshita, Kosaku
    Sakurai, Atsushi
    OPEN MEDICINE, 2023, 18 (01):
  • [45] Elevated triglyceride levels are associated with increased risk for major adverse cardiovascular events in statin-naive rheumatoid arthritis patients: A nationwide cohort study
    Choi, Wonsuk
    Kang, Ji-Hyoun
    Park, Ji Yong
    Hong, A. Ram
    Yoon, Jee Hee
    Kim, Hee Kyung
    Kang, Ho-Cheol
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 2023, 63
  • [46] Elevated heart rate: A major risk factor for cardiovascular disease
    Palatini, P
    Jullius, S
    CLINICAL AND EXPERIMENTAL HYPERTENSION, 2004, 26 (7-8) : 637 - 644
  • [47] Thiazolidinedione treatment is not associated with an increased risk of major adverse cardiovascular events
    Bilik, Dorian
    McEwen, Laura N.
    Selby, Joe V.
    Marrero, David G.
    Brown, Arleen F.
    Herman, William H.
    DIABETES, 2008, 57 : A85 - A85
  • [48] Systemic lupus erythematosus and the risk of perioperative major adverse cardiovascular events
    Nathaniel R. Smilowitz
    Gregory Katz
    Jill P. Buyon
    Robert M. Clancy
    Jeffrey S. Berger
    Journal of Thrombosis and Thrombolysis, 2018, 45 : 13 - 17
  • [49] Risk of major adverse cardiovascular and cerebrovascular events in Taiwanese women with endometriosis
    Chiang, Hsin-Ju
    Lan, Kuo-Chung
    Yang, Yao-Hsu
    Chiang, John Y.
    Kung, Fu-Tsai
    Huang, Fu-Jen
    Lin, Yu-Ju
    Su, Yu-Ting
    Sung, Pei-Hsun
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2021, 120 (01) : 327 - 336
  • [50] Systemic lupus erythematosus and the risk of perioperative major adverse cardiovascular events
    Smilowitz, Nathaniel R.
    Katz, Gregory
    Buyon, Jill P.
    Clancy, Robert M.
    Berger, Jeffrey S.
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2018, 45 (01) : 13 - 17
12345